Idiopathic intracranial hypertension in the USA: The role of obesity in establishing prevalence and healthcare costs

Obesity Reviews

Volumn 12, Issue 5, 2011, Pages

  Friesner, D ^a   Rosenman, R ^b   Lobb, B M ^c   Tanne, E ^c  

^a NORTH DAKOTA STATE UNIVERSITY   (United States)

^b WASHINGTON STATE UNIVERSITY   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Idiopathic intracranial hypertension; IIH; Pseudotumor cerebri

Indexed keywords

ADULT; ARTICLE; CEREBROSPINAL FLUID SHUNTING; COST EFFECTIVENESS ANALYSIS; FEMALE; HEALTH CARE COST; HUMAN; IDIOPATHIC DISEASE; INTRACRANIAL HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL FEE; OBESITY; PREVALENCE; UNITED STATES;

EID: 79955019474     PISSN: 14677881     EISSN: 1467789X     Source Type: Journal    
DOI: 10.1111/j.1467-789X.2010.00799.x     Document Type: Article

References (32)

1. Asensio-Sanchez VM, Merino-Angula J, Martinez-Calvo S, Calvo MJ, Rodriguez R. Epidemiology of pseudotumor cerebri. Arch Soc Esp Oftalmol 2007; 82: 219-221.
2. Kesler A, Gadoth N. Epidemiology of idiopathic intracranial hypertension in Israel. J Neuroophthalmol 2001; 21: 12-14.
3. Radhakrishnan K, Thacker AK, Bohlaga NH, Maloo JC, Gerryo SE. Epidemiology of idiopathic intracranial hypertension: a prospective and case-control study. J Neurol Sci 1993; 116: 18-28.
4. Digre KB, Corbett JJ. Idiopathic intracranial hypertension (pseudotumor cerebri): a reappraisal. Neurologist 2001; 7: 2-67.
5. Durcan FJ, Corbett JJ, Wall M. The incidence of pseudotumor cerebri: population studies in Iowa and Louisiana. Arch Neurol 1998; 45: 875-877.
6. Lueck C, McIlwaine G. Interventions for idiopathic intracranial hypertension. Cochrane Database Syst Rev 2005; 3: 1-9, 12.
7. Ball AK, Clark CE. Idiopathic intracranial hypertension. Lancet Neurol 2006; 5: 433-442.
8. Lehman CA. Idiopathic intracranial hypertension within the ICF model: a review of the literature. J Neurosci Nurs 2003; 35: 263-269.
9. Binder DK, Horton JC, Lawton MT, McDermott MW. Idiopathic intracranial hypertension. Neurosurgery 2004; 54: 538-551.
10. Friedman DI, Jacobson DM. Diagnostic criteria for idiopathic intracranial hypertension. Neurology 2002; 56: 1492-1495.
11. Mathews MK, Sergott RC, Savino PJ. Pseudotumor cerebri. Curr Opin Ophthalmol 2003; 14: 364-370.
12. Oo L-Y, Walker BR, Bodkin PA, Whittle IR. Idiopathic intracranial hypertension: can studies of obesity provide the key to understanding pathogensis? Br J Neurosurg 2008; 22: 187-194.
13. Daniels AB, Liu GT, Volpe NJ, Galetta SL, Moster ML, Newman NJ, Biousse V, Lee AG, Wall M, Kardon R, Acierno MD, Corbett JJ, Maguire MG, Balcer LJ. Profiles of obesity, weight gain, and quality of life in idiopathic intracranial hypertension (pseudotumor cerebri). Am J Ophthalmol 2007; 143: 635-641.
14. Digre KB. Idiopathic intracranial hypertension. Curr Treat Options Neurol 1999; 1: 74-81.
15. Kleinschmidt JJ, Digre KB, Hanover R. Idiopathic intracranial hypertension: relationship to depression, anxiety, and quality of life. Neurology 2000; 54: 319-324.
16. Glueck CJ, Iyengar S, Goldenberg N, Smith LS, Wang P. Idiopathic intracranial hypertension: associations with coagulation disorders and polycystic-ovary syndrome. J Lab Clin Med 2003; 142: 35-45.
17. Stevenson SB. Pseudotumor cerebri: yet another reason to fight obesity. Pediatr Health Care 2008; 22: 40-43.
18. Balcer LJ, Liu GT, Forman S, Pun K, Volpe NJ, Galetta SL, Maguire MG. Idiopathic intracranial hypertension: relation of age and obesity in children. Neurology 1999; 52: 870-872.
19. Gordon K. Pediatric pseudotumor cerebri: descriptive epidemiology. Can J Neurol Sci 1997; 24: 219-221.
20. Kesler A, Goldhammer Y, Gadoth N. Do men with pseudotumor cerebri share the same characteristics as women? A retrospective review of 141 cases. J Neuroophthalmol 2001; 2: 15-17.
21. Obesity in America.org. The Endocrine Society and Hormone Foundation. [WWW document]. URL (accessed October 2008).
22. U.S. Census Bureau. [WWW document]. URL (accessed October 2008).
23. Agency for Healthcare Research and Quality. HCUP Nationwide Inpatient Sample (NIS): Healthcare Cost and Utilization Project (HCUP). 2005. [WWW document]. URL (accessed October 2008).
24. Curry WJr, Butler W, Barker F. Rapidly rising incidence of cerebrospinal fluid shunting procedures for idiopathic intracranial hypertension in the United States, 1988-2002. Neurosurgery 2005; 57: 97-107.
25. Zhoa Y, Encinosa W. Bariatric surgery utilization and outcomes in 1998 and 2004. 2007. AHRQ Statistical Brief # 23. Agency for Healthcare Research and Quality. [WWW document]. URL (accessed October 2008).
26. U.S. Department of Health and Human Services. HHS Homepage. 2008. [WWW document]. URL (accessed October 2008).
27. Federal Reserve Bank of St. Louis. (n.d.). Economic Research. [WWW document]. URL (accessed October 2008).
28. Cinciripini GS, Donahue S, Borchert MS. Idiopathic intracranial hypertension in prepubertal pediatric patients: characteristics, treatment, and outcome. Am J Ophthalmol 1999; 127: 178-182.
29. Kesler A, Fattal-Valevski A. Idiopathic intracranial hypertension in the pediatric population. J Child Neurol 2002; 17: 745-748.
30. Sugerman HJ, Felton WL 3rd, Sismanis A, Kellum JM, DeMaria EJ, Sugerman EL. Gastric surgery for pseudotumor cerebri associated with severe obesity. Ann Surg 1999; 299: 634-640.
31. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006; 295: 1549-1555.
32. Center for Medicare and Medicaid Services (CMS). NHE08 Summary and GDP. 2008. [WWW document]. URL (accessed October 2008).